MarketPulse

drug efficacy

6 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

ImmunityBio Hit With Securities Fraud Lawsuit Over Alleged Cancer Drug Misrepresentation

ImmunityBio faces securities fraud lawsuit after executive allegedly misrepresented ANKTIVA cancer drug capabilities; stock fell 21% following FDA Warning Letter.
IBRXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

ALDX Stock Crashes 71% After FDA Rejects Reproxalap; Securities Probe Launched

Aldeyra Therapeutics plummets 71% after FDA rejects lead dry eye drug. Securities litigation firm investigating potential investor claims following efficacy concerns.
ALDXinvestor lossessecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Aldeyra Stock Plummets 71% After FDA Rejects Lead Drug; Law Firm Launches Investigation

Aldeyra Therapeutics stock plunged 71% after FDA rejected its reproxalap dry eye drug, prompting a securities investigation by Rosen Law Firm.
ITDNOWALDXstock declineinvestor losses
GlobeNewswire Inc.GlobeNewswire Inc.··Block & Leviton Llp

Aldeyra Therapeutics Stock Plummets 65% After FDA Rejection; Securities Fraud Investigation Launched

Aldeyra Therapeutics ($ALDX) shares crashed 65% following FDA rejection of reproxalap for dry eye disease. Law firm Block & Leviton investigates potential securities fraud.
EOSENUTXALDXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

Soleno Therapeutics Faces Class Action Over DCCR Safety Claims as Stock Plummets 27%

Robbins LLP launches class action against $SLNO over alleged investor deception regarding DCCR drug safety and efficacy for Prader-Willi syndrome treatment.
EOSEDRVNSLNOclass action lawsuitstock decline
The Motley FoolThe Motley Fool··Motley Fool Youtube

Novo Nordisk's Obesity Drug Underperforms Rival Zepbound in Late-Stage Trial

Novo Nordisk's Kagrama showed weaker weight-loss results than Eli Lilly's Zepbound in 84-week trial, pressuring obesity growth forecasts.
LLYNVOclinical trialweight loss